Sands Stephen H. 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Sands Stephen H.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-09$1.69/sh+12,129$20,498→ 12,129 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-09−12,129→ 0 totalExercise: $1.69From: 2024-02-03Exp: 2033-02-03→ Common Stock (12,129 underlying)